4.7 Article Proceedings Paper

Innovations and Challenges in Renal Cancer: Summary Statement From the Third Cambridge Conference

期刊

CANCER
卷 115, 期 10, 页码 2247-2251

出版社

WILEY
DOI: 10.1002/cncr.24229

关键词

renal cancer; genetics; vascular endothelial growth factor; immunotherapy; biomarkers

类别

资金

  1. Intramural NIH HHS [Z01 SC006659-25] Funding Source: Medline

向作者/读者索取更多资源

The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow. Cancer 2009;115(10 suppl):2247-51. (C) 2009 American Cancer Society.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据